Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
729 Leser
Artikel bewerten:
(2)

United Imaging Healthcare Co., Ltd.: United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%

Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report.

SHANGHAI, April 26, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023, marking a stable increase of 23.52%. Net income attributable to the shareholders of the parent company was 1.97 billion CNY, reflecting a YoY increase of 19.21 %.

The company also released its first quarter report for 2024. The report shows that in Q1 2024, United Imaging Healthcare recorded revenue of 2.35 billion CNY and net income attributable to the shareholders of 0.36 billion CNY, an increase of 6.22% and 10.20% respectively.

In the past year, United Imaging Healthcare has adhered to their globalization strategy, expanding the sales network to cover major developed and emerging markets around the world. By the end of 2023, the company's global customer base had covered over 65 countries and regions. The company has obtained more than 700 product registration certificates or quality management system certifications, with 45 products receiving CE certification and 44 products passing FDA 510(k) registrations, allowing them to be commercially available in the US. In 2023, the company's overseas main business achieved YoY growth of over 54.72 %, reaching 1.68 billion CNY. Notably, sales of the company's high-end equipment experienced rapid growth.

The expanding market share is bolstered by the company's steadfast commitment to research and development (R&D) innovation. The report illustrates that United Imaging Healthcare has made substantial investments in enhancing its technology and solutions in 2023, totaling 1.92 billion CNY.

In the past few years, United Imaging Healthcare has made new breakthroughs in collaborating with world-renowned universities and clinical and scientific research institutions such as Yale University and UC Davis, resulting in pioneering advancements like the advanced molecular imaging device for the brain. Complementing these collaborations, the company's commitment to healthcare accessibility is demonstrated by initiatives like partnering with GIC Prime in India and deploying a mobile PET/CT unit in Piacenza, Italy. These efforts underscore United Imaging Healthcare's dedication to "Equal Healthcare for All."

To embrace sustainability, United Imaging Healthcare always adheres to the core values of "DEI," which is diversity, equity, and inclusivity," regards employees as the core driving force to promote sustainable development of the enterprise, and firmly protects the basic rights of employees.

United Imaging Healthcare is committed to promoting a green enterprise and bolstering climate-related initiatives as a foundation for sustainable growth. The company's dedication is evident through continual enhancements to its environmental management system, adoption of eco-friendly and energy-efficient production methods, and vigilant monitoring of global climate shifts. As they pursue their own journey towards sustainability and strive for high-quality development, United Imaging Healthcare actively contributes to advancing ecological progress on a global scale.

About United Imaging Healthcare

At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.

Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All, we help drive industry progress and bold change.

To learn more, visit https://www.united-imaging.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/united-imaging-healthcare-releases-2023-annual-report-with-revenue-growth-of-23-52-302128731.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.